Pharmaceutical intermediates are chemical compounds widely used in manufacturing various types of drugs in bulk quantity and also used for research and development by Pharmaceutical and biopharma companies.
Pharmaceutical Intermediates Market - About the Report
Pharmaceutical intermediates are used as raw materials during the manufacture of bulk drugs. Leading biopharmaceutical and pharmaceutical manufacturing companies are focusing on improving their product footprint globally. These companies are focusing on strengthening their product reach in different countries across the world through various distribution channels. Growth outlook therefore remains positive for pharmaceutical intermediates market as companies continue focusing on enhancing the capacities of their manufacturing plants in various countries of the world.
In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors fuelling demand for pharmaceutical intermediates. The report tracks the global sales of pharmaceutical intermediates in 20+ high-growth markets, along with analyzing the impact COVID-19 has on the pharmaceutical industry in general and the market in particular.
Human brain imaging studies indicate that the medial prefrontal cortex activity can predict more than 80% of the variance of chronic back pain intensity. Therefore, the investigators have hypothesized that modulation of brain activity at this site should result in analgesia. D-cycloserine Intermediates have been shown to potentiate conditioned fear extinction. Based on this the investigators hypothesize that chronic neuropathic pain (back pain with radiculopathy) is partially mediated or potentiated by decreased ability to extinguish the pain memory, which the investigators hypothesize to be mediated through reward/aversion brain circuitry, and specifically through the medial prefrontal cortex. They have tested this idea in pre-clinical studies and demonstrated that rats with neuropathic pain show analgesia over the long term when treated with D-cycloserine. In humans with chronic back pain, the investigators hypothesize that D-cycloserine will enhance the extinction of back pain which in turn should result in reduced emotional relevance of the pain, that is reduced suffering. It is quite possible that the overall intensity of the back pain will be unaffected, however, the associated suffering will be significantly attenuated.
Atazanavir Intermediates are used along with other medications to treat human immunodeficiency virus (HIV) infection in adults and children who are at least 3 months of age and weigh at least 22 lb (10 kg). Atazanavir is in a class of medications called protease inhibitors. It works by decreasing the amount of HIV in the blood. Although atazanavir does not cure HIV, it may decrease your chance of developing acquired immunodeficiency syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer. Atazanavir must be given with other medications that treat HIV infection to completely treat the infection. Taking these medications along with practicing safer sex and making other lifestyle changes may decrease the risk of transmitting the HIV virus to other people.
How should this medicine be used?
Atazanavir comes as a capsule and as a powder to take by mouth. Atazanavir capsules are taken with food once a day and maybe given with a pharmacokinetic booster (medication given to increase the levels of another drug in the body) such as ritonavir or cobicistat. Atazanavir powder must be taken with food and ritonavir. Take atazanavir at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take atazanavir exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.